Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemia.
Bochtler T, Stölzel F, Heilig CE, Kunz C, Mohr B, Jauch A, Janssen JW, Kramer M, Benner A, Bornhäuser M, Ho AD, Ehninger G, Schaich M, Krämer A.
Bochtler T, et al. Among authors: jauch a.
J Clin Oncol. 2013 Nov 1;31(31):3898-905. doi: 10.1200/JCO.2013.50.7921. Epub 2013 Sep 23.
J Clin Oncol. 2013.
PMID: 24062393